Annual SG&A
$0.00$1.46B-100.00%
Summary
- Current Value
- As of today, VRTX annual SG&A is $0.00, down -100.00% on
- Historical Performance
- VRTX annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- VRTX annual SG&A is currently -100.00% below its historical high of $1.46B set on
- Sector Comparison
- VRTX annual SG&A is higher than 70.87% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $844.10M | +89.6% | +220.0% | +325.9% | +662.8% | |
| TTM SG&A | $60.19B | +3561.7% | +5715.8% | +7453.9% | +10000.0% | |
| Price | $537.79 | +23.9% | +53.4% | +185.7% | +1753.8% | |
| Annual Operating Expenses | $5.68B | +11.6% | +58.4% | +118.6% | +615.0% | |
| Annual Operating Profit | $4.69B | +7.5% | +14.9% | +63.1% | +774.9% | |
| Annual D&A | $209.80M | +1.3% | +41.5% | +91.6% | +588.8% | |
| Annual Revenue | $12.07B | +9.9% | +38.0% | +94.5% | +8322.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.46B | -100.0% | |
| 5Y | $1.46B | -100.0% | |
| All | $1.46B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
- What is the current annual SG&A of VRTX?
- As of today, VRTX annual SG&A is $0.00
- What is 1-year change in VRTX annual SG&A?
- VRTX annual SG&A is down -100.00% year-over-year
- What is 3-year change in VRTX annual SG&A?
- VRTX annual SG&A is down -100.00% over the past 3 years
- How far is VRTX annual SG&A from its all-time high?
- VRTX annual SG&A is currently -100.00% below its historical high of $1.46B set on December 31, 2024
- How does VRTX annual SG&A rank versus sector peers?
- VRTX annual SG&A is higher than 70.87% of companies in Healthcare sector
- When is VRTX next annual earnings release?
- The next annual earnings release for VRTX is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Quarterly SG&A
$844.10M$261.90M+44.98%
Summary
- Current Value
- As of today, VRTX quarterly SG&A is $844.10M, up +44.98% on
- Historical Performance
- VRTX quarterly SG&A is up +89.64% year-over-year, up +219.98% over the past 3 years
- All-Time High Comparison
- VRTX quarterly SG&A is currently at its all-time high
- 3-Year Low Comparison
- VRTX quarterly SG&A is +219.98% above its 3-year low of $263.80M reached on an earlier date
- Sector Comparison
- VRTX quarterly SG&A is higher than 97.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $844.10M | +45.0% | +89.6% | +220.0% | +325.9% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $60.19B | +2897.4% | +3561.7% | +5715.8% | +7453.9% | |
| Price | $537.79 | +4.3% | +23.9% | +53.4% | +185.7% | |
| Quarterly Operating Expenses | $2.11B | +33.6% | +48.0% | +87.1% | +204.3% | |
| Quarterly Operating Profit | $1.25B | -2.1% | -2.0% | +20.8% | +18.0% | |
| Quarterly D&A | $69.20M | +22.5% | +28.1% | +64.4% | +118.3% | |
| Quarterly Revenue | $3.44B | +2.8% | +10.4% | +38.6% | +72.9% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $844.10M | at high | |
| 3Y | $844.10M | at high | |
| 5Y | $844.10M | at high | |
| All | $844.10M | at high |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $445.10M | N/A | +89.6% |
| 3Y | $263.80M | N/A | +220.0% |
| 5Y | $198.19M | N/A | +325.9% |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
- What is the current quarterly SG&A of VRTX?
- As of today, VRTX quarterly SG&A is $844.10M
- What is VRTX quarterly SG&A most recent change?
- VRTX quarterly SG&A was up +44.98% on September 30, 2026
- What is 1-year change in VRTX quarterly SG&A?
- VRTX quarterly SG&A is up +89.64% year-over-year
- How far is VRTX quarterly SG&A from its all-time high?
- VRTX quarterly SG&A is currently at its all-time high
- How does VRTX quarterly SG&A rank versus sector peers?
- VRTX quarterly SG&A is higher than 97.28% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
TTM SG&A
$60.19B$3.98B+7.07%
Summary
- Current Value
- As of today, VRTX TTM SG&A is $60.19B, up +7.07% on
- Historical Performance
- VRTX TTM SG&A is up +3561.70% year-over-year, up +5715.77% over the past 3 years
- All-Time High Comparison
- VRTX TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- VRTX TTM SG&A is +93.79% above its 3-year low of $31.06B reached on an earlier date
- Sector Comparison
- VRTX TTM SG&A is higher than 97.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $60.19B | +2897.4% | +3561.7% | +5715.8% | +7453.9% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $844.10M | +45.0% | +89.6% | +220.0% | +325.9% | |
| Price | $537.79 | +4.3% | +23.9% | +53.4% | +185.7% | |
| TTM Operating Profit | $5.00B | -0.5% | +10.3% | +30.8% | +85.0% | |
| TTM D&A | $237.30M | +6.8% | +18.3% | +47.7% | +95.9% | |
| TTM Revenue | $13.02B | +2.5% | +11.0% | +36.1% | +81.3% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $60.19B | N/A | at high |
| 3Y | $60.19B | N/A | at high |
| 5Y | $60.19B | N/A | at high |
| All | $60.19B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $43.51B | N/A | +38.3% |
| 3Y | $31.06B | N/A | +93.8% |
| 5Y | $6.38B | N/A | +843.4% |
| All | -$21.45B | N/A | +380.6% |
TTM SG&A History
FAQ
- What is the current TTM SG&A of VRTX?
- As of today, VRTX TTM SG&A is $60.19B
- What is VRTX TTM SG&A most recent change?
- VRTX TTM SG&A was up +7.07% on September 30, 2026
- What is 1-year change in VRTX TTM SG&A?
- VRTX TTM SG&A is up +3561.70% year-over-year
- How far is VRTX TTM SG&A from its all-time high?
- VRTX TTM SG&A is currently at its all-time high
- How does VRTX TTM SG&A rank versus sector peers?
- VRTX TTM SG&A is higher than 97.92% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx
